Neumora Therapeutics, Inc. (NMRA)
0.8313
-0.17
(-16.82%)
USD |
NASDAQ |
Sep 15, 16:00
0.8301
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Price : 0.8313 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 1.02 | 1.03 | 0.83 | 0.8313 | 1.420M |
| Sep 14, 2026 | 1.03 | 1.06 | 0.99 | 0.9994 | 555259.0 |
| Sep 11, 2026 | 1.16 | 1.16 | 1.02 | 1.04 | 1.881M |
| Sep 10, 2026 | 1.20 | 1.21 | 1.115 | 1.14 | 600848.0 |
| Sep 09, 2026 | 1.26 | 1.265 | 1.19 | 1.20 | 586948.0 |
| Sep 08, 2026 | 1.29 | 1.34 | 1.24 | 1.25 | 757238.0 |
| Sep 04, 2026 | 1.35 | 1.36 | 1.29 | 1.31 | 549209.0 |
| Sep 03, 2026 | 1.39 | 1.39 | 1.34 | 1.35 | 386040.0 |
| Sep 02, 2026 | 1.35 | 1.41 | 1.345 | 1.38 | 532233.0 |
| Sep 01, 2026 | 1.33 | 1.36 | 1.31 | 1.33 | 532617.0 |
| Aug 31, 2026 | 1.40 | 1.445 | 1.32 | 1.33 | 633100.0 |
| Aug 28, 2026 | 1.50 | 1.51 | 1.38 | 1.39 | 696286.0 |
| Aug 27, 2026 | 1.55 | 1.575 | 1.48 | 1.48 | 534040.0 |
| Aug 26, 2026 | 1.50 | 1.57 | 1.46 | 1.56 | 536190.0 |
| Aug 25, 2026 | 1.53 | 1.57 | 1.48 | 1.50 | 475568.0 |
| Aug 24, 2026 | 1.58 | 1.65 | 1.51 | 1.525 | 1.155M |
| Aug 21, 2026 | 1.51 | 1.64 | 1.51 | 1.63 | 499105.0 |
| Aug 20, 2026 | 1.61 | 1.63 | 1.475 | 1.515 | 1.486M |
| Aug 19, 2026 | 1.65 | 1.71 | 1.615 | 1.64 | 716166.0 |
| Aug 18, 2026 | 1.50 | 1.65 | 1.48 | 1.64 | 781775.0 |
| Aug 17, 2026 | 1.55 | 1.585 | 1.46 | 1.52 | 1.353M |
| Aug 14, 2026 | 1.69 | 1.71 | 1.58 | 1.60 | 1.166M |
| Aug 13, 2026 | 1.71 | 1.785 | 1.675 | 1.73 | 488293.0 |
| Aug 12, 2026 | 1.70 | 1.76 | 1.675 | 1.71 | 351606.0 |
| Aug 11, 2026 | 1.62 | 1.70 | 1.61 | 1.70 | 517500.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 267.20 |
| Indivior Pharmaceuticals, Inc. | 34.22 |
| Liquidia Corp. | 65.72 |
| BioAge Labs, Inc. | 8.18 |
| LB Pharmaceuticals, Inc. | 43.04 |
Price Related Metrics
| Price to Book Value | 3.489 |
| Earnings Yield | -148.4% |
| Market Cap | 155.33M |